KR102517807B1 - Drinking powder composition for boosting body-energy and Drinking powder for boosting body-energy containing the same - Google Patents
Drinking powder composition for boosting body-energy and Drinking powder for boosting body-energy containing the same Download PDFInfo
- Publication number
- KR102517807B1 KR102517807B1 KR1020220112615A KR20220112615A KR102517807B1 KR 102517807 B1 KR102517807 B1 KR 102517807B1 KR 1020220112615 A KR1020220112615 A KR 1020220112615A KR 20220112615 A KR20220112615 A KR 20220112615A KR 102517807 B1 KR102517807 B1 KR 102517807B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- body energy
- drink powder
- sweetener
- collagen
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 230000035622 drinking Effects 0.000 title 2
- 102000008186 Collagen Human genes 0.000 claims abstract description 85
- 229920001436 collagen Polymers 0.000 claims abstract description 85
- 108010035532 Collagen Proteins 0.000 claims abstract description 84
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 47
- 238000010521 absorption reaction Methods 0.000 claims abstract description 34
- 150000001413 amino acids Chemical class 0.000 claims abstract description 29
- 210000003205 muscle Anatomy 0.000 claims abstract description 29
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 28
- 239000003765 sweetening agent Substances 0.000 claims abstract description 28
- 238000011084 recovery Methods 0.000 claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 20
- 239000002699 waste material Substances 0.000 claims abstract description 18
- 229940124549 vasodilator Drugs 0.000 claims abstract description 15
- 239000003071 vasodilator agent Substances 0.000 claims abstract description 15
- 230000003472 neutralizing effect Effects 0.000 claims abstract description 5
- 229940024606 amino acid Drugs 0.000 claims description 28
- 235000001014 amino acid Nutrition 0.000 claims description 28
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 20
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 235000019156 vitamin B Nutrition 0.000 claims description 14
- 229940069978 calcium supplement Drugs 0.000 claims description 13
- 239000011720 vitamin B Substances 0.000 claims description 13
- 229940046001 vitamin b complex Drugs 0.000 claims description 13
- 240000000111 Saccharum officinarum Species 0.000 claims description 11
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 11
- 239000008122 artificial sweetener Substances 0.000 claims description 11
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 10
- 229930182844 L-isoleucine Natural products 0.000 claims description 10
- 239000004395 L-leucine Substances 0.000 claims description 10
- 235000019454 L-leucine Nutrition 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 229960000310 isoleucine Drugs 0.000 claims description 10
- 229960003136 leucine Drugs 0.000 claims description 10
- 229940029985 mineral supplement Drugs 0.000 claims description 10
- 235000020786 mineral supplement Nutrition 0.000 claims description 10
- 235000021096 natural sweeteners Nutrition 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 239000000787 lecithin Substances 0.000 claims description 9
- 229940067606 lecithin Drugs 0.000 claims description 9
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 9
- 229960004295 valine Drugs 0.000 claims description 9
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019163 vitamin B12 Nutrition 0.000 claims description 7
- 239000011715 vitamin B12 Substances 0.000 claims description 7
- GGTYBZJRPHEQDG-WCCKRBBISA-N (2s)-2,5-diaminopentanoic acid hydrochloride Chemical compound Cl.NCCC[C@H](N)C(O)=O GGTYBZJRPHEQDG-WCCKRBBISA-N 0.000 claims description 6
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004386 Erythritol Substances 0.000 claims description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- 229960004543 anhydrous citric acid Drugs 0.000 claims description 6
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 6
- 239000000605 aspartame Substances 0.000 claims description 6
- 235000010357 aspartame Nutrition 0.000 claims description 6
- 229960003438 aspartame Drugs 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 229940009714 erythritol Drugs 0.000 claims description 6
- 235000019414 erythritol Nutrition 0.000 claims description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- 229960003244 ornithine hydrochloride Drugs 0.000 claims description 6
- 235000019408 sucralose Nutrition 0.000 claims description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 5
- 229930064664 L-arginine Natural products 0.000 claims description 5
- 235000014852 L-arginine Nutrition 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 5
- 229960002079 calcium pantothenate Drugs 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 235000013379 molasses Nutrition 0.000 claims description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 229940057070 sugarcane extract Drugs 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 239000004267 EU approved acidity regulator Substances 0.000 claims description 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 244000228451 Stevia rebaudiana Species 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 235000013376 functional food Nutrition 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 5
- 208000000112 Myalgia Diseases 0.000 abstract description 4
- 208000013465 muscle pain Diseases 0.000 abstract description 4
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 31
- 102000004196 processed proteins & peptides Human genes 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 206010016256 fatigue Diseases 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 9
- 229960002591 hydroxyproline Drugs 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 9
- 241000544066 Stevia Species 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 235000011496 sports drink Nutrition 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 229930182816 L-glutamine Natural products 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 4
- 235000015277 pork Nutrition 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 3
- 206010024264 Lethargy Diseases 0.000 description 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000004227 calcium gluconate Substances 0.000 description 3
- 229960004494 calcium gluconate Drugs 0.000 description 3
- 235000013927 calcium gluconate Nutrition 0.000 description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 3
- 239000001527 calcium lactate Substances 0.000 description 3
- 235000011086 calcium lactate Nutrition 0.000 description 3
- 229940041131 calcium lactate gluconate Drugs 0.000 description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 3
- 229960002173 citrulline Drugs 0.000 description 3
- 235000013477 citrulline Nutrition 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- OVGXLJDWSLQDRT-CEOVSRFSSA-L magnesium;(2s)-2-hydroxypropanoate Chemical compound [Mg+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O OVGXLJDWSLQDRT-CEOVSRFSSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940117953 phenylisothiocyanate Drugs 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- UNYNVICDCJHOPO-UHFFFAOYSA-N sotolone Chemical compound CC1OC(=O)C(O)=C1C UNYNVICDCJHOPO-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000006243 Oenanthe sarmentosa Species 0.000 description 1
- 235000004199 Oenanthe sarmentosa Nutrition 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 235000003828 Sium suave Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 235000019223 lemon-lime Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- JOQGJRQKCIJIDB-UHFFFAOYSA-N tin;hydrochloride Chemical compound Cl.[Sn] JOQGJRQKCIJIDB-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
- A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/37—Halogenated sugars
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
본 발명은 신체 에너지를 활성화시키는 일반식품 및/또는 건강기능식품으로서, 분말로 섭취하거나 물에 타서 음료로 섭취할 수 있는 신체 에너지 활성 드링크 분말 및 이의 제조에 사용되는 조성물에 관한 것이다.The present invention relates to a body energy active drink powder that can be consumed as a powder or mixed with water as a beverage as a general food and/or health functional food that activates body energy, and a composition used for preparing the same.
우리 몸은 장시간 높은 강도의 운동이나 활동을 지속하면 몸에서 열이 발생하면서 이로 인하여 피가 뜨거워지며, 심장에 과부하가 생기어서 혈액순환이 원활하지 못하게 되어 산소와 수분이 부족하게 되는 문제와 함께 에너지 소비로 인한 에너지부족 현상이 발생하고 호흡곤란, 체력저하 등의 문제가 야기되고, 피로가 축적되며, 이러한 피로 축적은 고도의 집중력을 요하는 스포츠의 경기력을 크게 좌우한다.When our body continues high-intensity exercise or activity for a long time, heat is generated in the body, which causes the blood to become hot. Energy shortage occurs due to consumption, and problems such as difficulty breathing and physical decline occur, and fatigue accumulates, and such fatigue accumulation greatly influences performance in sports requiring high concentration.
이러한 에너지 부족, 수분 부족을 방지하고, 회복하기 위하여 물을 섭취하거나, 빠른 운동수행능력의 회복을 위해서 나트륨, 칼륨, 마그네슘, 칼슘 등의 전해질 성분 함유한 스포츠 음료를 섭취한다. Water is consumed to prevent and recover from lack of energy and moisture, or sports drinks containing electrolytes such as sodium, potassium, magnesium, and calcium are consumed to quickly recover exercise performance.
운동능력 향상, 피로 회복 촉진을 위한 다양한 스포츠 음료가 개발, 판매되고 있으며, 스포츠 음료 또는 관련 건강기능식품에 대한 시장은 지속적으로 확대되고 있는 실정이다.Various sports drinks for improving exercise capacity and promoting recovery from fatigue are being developed and sold, and the market for sports drinks or related health functional foods is continuously expanding.
스포츠 음료 등의 건강기능식품은 기존 이온 음료가 갖는 수분과 전해질 보급이라는 기본적인 기능 외에 고기능성, 구체적으로 근육 형성이나 운동력 향상 등 고기능성 역할이 추가된 고기능성 건강기능식품으로 발전되고 있다.Health functional foods such as sports drinks are being developed into high-functional health functional foods that have added high-functionality, such as muscle building or exercise power improvement, in addition to the basic function of supplying water and electrolytes that existing ionic drinks have.
예를 들면, 대한민국 공개특허 제10-2015-0081034호에서는 인삼, 오미자 및 맥분동 등의 한약재를 포함하는 스포츠 음료 조성물을 제안하였고, 대한민국 공개특허 제10-2014-0081132호에서는 미나리 추출물을 활용하는 스포츠 음료 조성물을 제안하였다.For example, Korean Patent Publication No. 10-2015-0081034 proposed a sports drink composition containing herbal medicines such as ginseng, Schisandra chinensis, and pulse, and Korean Patent Publication No. 10-2014-0081132, which utilizes water parsley extract. A sports drink composition is proposed.
그러나 이러한 선행문헌들은 기타 추출물의 함량이 높아짐으로써 여러 기능성을 가져왔지만, 실질적으로 기타 기능성 원료들로 인하여 운동 후 빠른 수분공급 및 전해질 공급의 기본 기능이 약화되는 등의 단점이 있었다.However, although these prior literatures have various functionalities by increasing the content of other extracts, they have disadvantages such as weakening the basic functions of rapid water supply and electrolyte supply after exercise due to substantially other functional raw materials.
그리고, 대한민국 공개특허 2017-0137703호에서는 콜라겐을 이용한 음료가 제안된 바 있는데, 콜라겐의 체내 흡수율이 낮고, 신체 에너지 활성을 위한 식품으로서 기능성이 부족하여 상품성이 떨어지는 단점이 있다.In addition, Korean Patent Publication No. 2017-0137703 proposes a beverage using collagen, which has a low absorption rate in the body and lacks functionality as a food for activating body energy, resulting in poor marketability.
또한, 신체 에너지 활성 건강기능식품으로 기존 스포츠 음료는 부피를 차지하는 용기 형태로 제공되어 보관 및 소지가 용이하지 않고, 운동 중 큰 부피의 용기를 소지하고 다녀야하는 번거러움이 있다.In addition, existing sports drinks as health functional food for activating body energy are provided in the form of a bulky container, making it difficult to store and carry.
본 발명은 외부 활동이나, 운동시 섭취하면 신체에 에너지를 공급하여 신체 활력을 부여하여 빠른 피로 회복을 유도하고, 근손실 방지를 통해 부상 및 근육통을 예방할 수 있으면서, 소지가 편리하도록 파우치 형태로 제공할 수 있는 신체 에너지 활성 드링크 분말 및 이의 제조에 사용되는 최적의 조성 및 조성비를 가지는 조성물을 제공하고자 한다. The present invention is provided in the form of a pouch for convenient carrying while inducing rapid recovery from fatigue by supplying energy to the body when ingested during outdoor activities or exercise to give vitality to the body, and preventing injury and muscle pain by preventing muscle loss. It is an object of the present invention to provide a body energy active drink powder and a composition having an optimal composition and composition ratio used in its preparation.
상기 과제를 해결하기 위한 본 발명의 신체 에너지 활성 드링크 분말 조성물은 복합 아미노산, 콜라겐 펩타이드, 혈관 확장제, 근육회복제, 노폐물 중성화제 및 감미료를 포함한다.The body energy active drink powder composition of the present invention for solving the above problems includes complex amino acids, collagen peptides, vasodilators, muscle recovery agents, waste neutralizers, and sweeteners.
본 발명의 바람직한 일실시예로서, 상기 조성물의 복합 아미노산은 L-로이신, L-이소로이신, L-발린 및 L-레시틴 중에서 선택된 2종 이상을 포함할 수 있다.As a preferred embodiment of the present invention, the complex amino acid of the composition may include at least two selected from L-leucine, L-isoleucine, L-valine and L-lecithin.
본 발명의 바람직한 일실시예로서, 상기 조성물의 콜라겐 펩타이드는 300 Da 이하의 저분자량 콜라겐 펩타이드를 포함할 수 있다.As a preferred embodiment of the present invention, the collagen peptides of the composition may include low molecular weight collagen peptides of 300 Da or less.
본 발명의 바람직한 일실시예로서, 상기 조성물의 혈관 확장제는 L-아르기닌(arginine) 및 시트롤린(citrulliine) 선택된 1종 이상을 포함할 수 있다.As a preferred embodiment of the present invention, the vasodilator of the composition may include at least one selected from L-arginine and citrulline.
본 발명의 바람직한 일실시예로서, 상기 조성물의 근육회복제는 L-글루타민(glutamine) 및 비타민 B 복합제를 포함할 수 있다.As a preferred embodiment of the present invention, the muscle recovery agent of the composition may include L- glutamine and vitamin B complex.
본 발명의 바람직한 일실시예로서, 상기 비타민 B 복합제는 판토텐산칼슘 20 ~ 25 중량%, 비타민B6 염산염 5 ~ 10 중량%, 비타민 B1 염산염 4.0 ~ 7.0 중량%, 비타민 B2 3 ~ 7 중량%, 비타민 B12 2.5 ~ 5.0 중량%, 엽산 0.5 ~ 2.0 중량% 및 100 중량% 중 나머지 잔량의 니코티난 아마이드를 포함할 수 있다.As a preferred embodiment of the present invention, the vitamin B complex contains 20 to 25% by weight of calcium pantothenate, 5 to 10% by weight of vitamin B6 hydrochloride, 4.0 to 7.0% by weight of vitamin B1 hydrochloride, 3 to 7% by weight of vitamin B2, and vitamin B12. 2.5 to 5.0% by weight, 0.5 to 2.0% by weight of folic acid, and 100% by weight of the remainder of nicotinan amide.
본 발명의 바람직한 일실시예로서, 상기 조성물의 노폐물 중성화제는 DL-말릭산(Malic acid), 무수구연산 및 오르니틴염산염을 포함할 수 있다.As a preferred embodiment of the present invention, the waste neutralizer of the composition may include DL-malic acid, anhydrous citric acid, and ornithine hydrochloride.
본 발명의 바람직한 일실시예로서, 상기 조성물의 감미료는 천연 감미료 및 인공 감미료를 포함할 수 있다.As a preferred embodiment of the present invention, the sweetener of the composition may include a natural sweetener and an artificial sweetener.
본 발명의 바람직한 일실시예로서, 상기 천연 감미료는 자일리톨(xylitol), 효소 처리 스테비아(stevia), 팔라티노스(palatinose) 및 에리스리톨(erythritol) 중에서 선택된 1종 이상을 포함할 수있다. As a preferred embodiment of the present invention, the natural sweetener may include at least one selected from xylitol, enzyme-treated stevia, palatinose, and erythritol.
본 발명의 바람직한 일실시예로서, 상기 인공 감미료는 아스파탐, 수크랄로스 및 사탕수수 가공 감미료 중에서 선택된 1종 이상을 포함할 수 있다.As a preferred embodiment of the present invention, the artificial sweetener may include at least one selected from aspartame, sucralose, and sugar cane processed sweetener.
본 발명의 바람직한 일실시예로서, 상기 사탕수수 가공 감미료는 사탕수수 추출물 2.0 ~ 5.0 중량%, 당밀 추출물 1.0 ~ 3.0 중량%, 글리세린 0.50 ~ 1.50 중량%, 합성향료 0.5 ~ 2.0 중량% 및 100 중량% 중 나머지 잔량의 덱스트린을 포함할 수 있다.As a preferred embodiment of the present invention, the sugarcane processed sweetener contains 2.0 to 5.0% by weight of sugarcane extract, 1.0 to 3.0% by weight of molasses extract, 0.50 to 1.50% by weight of glycerin, 0.5 to 2.0% by weight and 100% by weight of synthetic flavoring agent. Among them, the remaining amount of dextrin may be included.
본 발명의 바람직한 일실시예로서, 본 발명의 상기 조성물은 콜라겐 흡수 보조제, 항산화제, 미네랄 보충제, 칼슘 보충제, 산도조절제 및 향료 중에서 선택된 1종 이상을 더 포함할 수도 있다.As a preferred embodiment of the present invention, the composition of the present invention may further include at least one selected from collagen absorption aids, antioxidants, mineral supplements, calcium supplements, acidity regulators and flavoring agents.
본 발명의 다른 목적은 앞서 설명한 조성물의 혼합물을 포함하는 신체 에너지 활성 드링크 분말에 관한 것이다.Another object of the present invention relates to a body energy active drink powder comprising a mixture of the compositions described above.
본 발명의 바람직한 일실시예로서, 본 발명의 신체 에너지 활성 드링크 분말은 상기 혼합물 10g 당 아미노산 함량 3,000 ~ 7,000 mg 및 콜라겐 펩타이드 함량 800 mg 이상으로 포함할 수 있다.As a preferred embodiment of the present invention, the body energy active drink powder of the present invention may contain 3,000 to 7,000 mg of amino acid content and 800 mg or more of collagen peptide content per 10 g of the mixture.
본 발명의 신체 에너지 활성 드링크 분말 조성물은 최적 함량으로 특정 성분들을 포함하는 바, 이로 제조한 신체 에너지 활성 드링크 분말은 콜라겐의 체내 흡수가 빠르고, 콜라겐 외의 기능성 성분들 역시 체내 흡수가 매우 빨라서 신체에 에너지 전달력이 매우 우수하다. 그리고, 본 발명의 신체 에너지 활성 드링크 분말은 물에 타서 먹거나, 물 없이 분말 자체 그대로 섭취가 가능하며, 무설탕, 무카페인, 무방부제이며, 맛이 좋아서 당뇨 환자뿐만 아니라 남녀노소 누구나 부담없이 섭취가 가능하다. 본 발명의 신체 에너지 활성 드링크 분말은 다양한 스포츠와 같은 신체 활동 전, 활동 중 또는 활동 후에 섭취시 신체 활동 능력 향상, 집중력 향상 효과가 있으며, 근손실 방지, 근육통 예방 및 피로 회복 효과가 매우 우수하다.The body energy active drink powder composition of the present invention contains specific ingredients in an optimal amount, and the body energy active drink powder prepared therefrom has fast absorption of collagen into the body, and functional ingredients other than collagen are also absorbed very quickly into the body. Transmission is very good. In addition, the body energy active drink powder of the present invention can be eaten with water or consumed as the powder itself without water, and is sugar-free, caffeine-free, and preservative-free, and tastes good, so not only diabetic patients but also people of all ages can consume it without any burden. do. The body energy active drink powder of the present invention has an effect of improving physical activity ability and concentration when consumed before, during or after physical activity such as various sports, and has excellent effects in preventing muscle loss, preventing muscle pain, and recovering from fatigue.
도 1은 실시예 1에서 제조한 신체 에너지 활성 드링크 분말을 파우치(1회용 포장체)에 포장한 사진이다.1 is a photograph of the body energy active drink powder prepared in Example 1 packaged in a pouch (disposable package).
이하 본 발명을 더욱 자세하게 설명한다.Hereinafter, the present invention will be described in more detail.
신체 에너지 활성 드링크 분말은 콜라겐과 아미노산 등 기능성 성분을 다량 포함하면서도, 물에 잘 용해되고, 신체 흡수율이 우수한 건강기능식품이다.Body energy active drink powder is a health functional food that contains a large amount of functional ingredients such as collagen and amino acids, but is well soluble in water and has excellent body absorption rate.
이러한, 본 발명의 신체 에너지 활성 드링크 분말은 다양한 형태로 제조, 판매할 수 있으며, 소지 및 보관이 용이하도록 파우치 형태(예를 들면, 스틱포장), 캔(can) 형태로도 제조할 수 있다.The body energy active drink powder of the present invention can be manufactured and sold in various forms, and can be manufactured in a pouch form (eg, stick packaging) or can form for easy carrying and storage.
일례를 들면, 1개의 포 당 5 ~ 20g씩, 바람직하게는 8 ~ 15g씩 신체 에너지 활성 드링크 분말을 포함하도록 파우치화하여 제공할 수 있다.For example, 5 to 20 g per pouch, preferably 8 to 15 g of body energy active drink powder may be provided in pouch form.
본 발명의 신체 에너지 활성 드링크 분말은 아미노산과 콜라겐 펩타이드를 고함량 포함할 수 있는데, 구체적인 예를 들면, 10g 당 아미노산 함량 3,000 ~ 7,000 mg 및 콜라겐 펩타이드 함량 800 mg 이상으로 포함할 수 있으며, 바람직하게는 10g 당 아미노산 함량 3,500 ~ 6,500 mg 및 콜라겐 펩타이드 함량 900 ~ 2000 mg으로 포함할 수 있고, 더욱 바람직하게는 10g 당 아미노산 함량 3,700 ~ 6,000 mg 및 콜라겐 펩타이드 함량 950 ~ 1,800 mg으로, 아미노산과 콜라겐 펩타이드를 고함량으로 포함할 수 있다.The body energy active drink powder of the present invention may contain amino acids and collagen peptides in high content, for example, amino acid content of 3,000 to 7,000 mg and collagen peptide content of 800 mg or more per 10 g, preferably 3,500 to 6,500 mg of amino acids and 900 to 2000 mg of collagen peptides per 10 g, more preferably 3,700 to 6,000 mg of amino acids and 950 to 1,800 mg of collagen peptides per 10 g of amino acids and collagen peptides content can be included.
그리고, 본 발명의 신체 에너지 활성 드링크 분말은 물에 타서 음료수로 제조하여 마시는 경우, 수분 보충과 함께, 체내 흡수를 극대화되어 섭취 후 30분 이내에 빠른 신체 에너지 활성화가 가능하다. In addition, when the body energy active drink powder of the present invention is mixed with water and prepared as a beverage, absorption in the body is maximized along with moisture replenishment, so that rapid body energy activation is possible within 30 minutes after ingestion.
본 발명의 신체 에너지 활성 드링크 분말 제조에 사용되는 조성물에 대해 설명하면 다음과 같다.The composition used for preparing the body energy active drink powder of the present invention is described as follows.
본 발명의 신체 에너지 활성 드링크 분말 조성물은 아미노산, 콜라겐 펩타이드를 고함량으로 포함하면서도, 제품의 물에 대한 용해성, 체내 흡수성, 에너지 전달성의 기능성 고려하면서, 맛과 향 등 상품성을 고려한 최적의 조성 및 조성비를 가지는 건강기능식품 조성물이다.The body energy active drink powder composition of the present invention includes a high content of amino acids and collagen peptides, while considering the solubility of the product in water, absorption in the body, and energy transmission functionality, optimal composition and composition ratio in consideration of marketability such as taste and aroma It is a health functional food composition having a.
본 발명의 상기 조성물은 복합 아미노산, 콜라겐 펩타이드, 혈관 확장제, 근육회복제, 노폐물 중성화제 및 감미료를 포함한다.The composition of the present invention includes complex amino acids, collagen peptides, a vasodilator, a muscle recovery agent, a waste product neutralizer, and a sweetener.
본 발명의 조성물 중 상기 복합 아미노산은 근육에 에너지원을 공급하고, 근지구력 상승, 근손실을 방지하여 운동 후 근육통 방지 내지 최소화, 피로도 감소, 피로회복을 유도하는 역할을 하는 것으로서, L-로이신, L-이소로이신, L-발린 및 L-레시틴 중에서 선택된 2종 이상을 포함할 수 있으며, 바람직하게는 3 종 이상을 포함하며, 더욱 바람직하게는 아미노산은 L-로이신, L-이소로이신, L-발린 및 L-레시틴을 모두 포함할 수 있다. The complex amino acids in the composition of the present invention supply energy to muscles, increase muscular endurance, prevent muscle loss, prevent or minimize muscle pain after exercise, reduce fatigue, and induce fatigue recovery, L-leucine, L-isoleucine, L-valine and L-lecithin may include two or more selected from, preferably three or more, more preferably amino acids L-leucine, L-isoleucine, L- It may include both valine and L-lecithin.
본 발명에서 상기 복합 아미노산은 복합 아미노산 성분으로서, L-로이신, L-이소로이신, L-발린 및 L-레시틴 4종을 모두 사용하는 경우, L-로이신 100 중량부에 대하여 L-이소로이신 30 ~ 80 중량부, L-발린 30 ~ 80 중량부 및 L-레시틴 0.01 ~ 1.00 중량부를, 바람직하게는 , L-로이신 100 중량부에 대하여 L-이소로이신 40 ~ 65 중량부, L-발린 40 ~ 65 중량부 및 L-레시틴 0.02 ~ 0.80 중량부를, 더욱 바람직하게는 L-로이신 100 중량부에 대하여 L-이소로이신 42 ~ 60 중량부, L-발린 45 ~ 58 중량부 및 L-레시틴 0.05 ~ 0.70 중량부를 포함하는 것이, 드링크 분말의 용해성, 아미노산 체내 흡수률, 빠른 신체 활력 강화 측면에서 유리하다.In the present invention, the complex amino acid is a complex amino acid component, and when all four types of L-leucine, L-isoleucine, L-valine, and L-lecithin are used, 30 to 30 parts of L-isoleucine based on 100 parts by weight of L-leucine. 80 parts by weight, 30 to 80 parts by weight of L-valine and 0.01 to 1.00 parts by weight of L-lecithin, preferably 40 to 65 parts by weight of L-isoleucine, 40 to 65 parts by weight of L-leucine, based on 100 parts by weight of L-leucine parts by weight and 0.02 to 0.80 parts by weight of L-lecithin, more preferably 42 to 60 parts by weight of L-isoleucine, 45 to 58 parts by weight of L-valine and 0.05 to 0.70 parts by weight of L-lecithin based on 100 parts by weight of L-leucine It is advantageous in terms of the solubility of the drink powder, the absorption rate of amino acids in the body, and the rapid enhancement of body vitality.
콜라겐의 다양한 유익한 특성을 가지며, 연골, 각막, 혈관, 및 피부 등을 구성하며, 인간 결합 조직의 주요 단백질이다. 또한 콜라겐은 견고하고 비연신성이며 인장 강도가 뛰어나, 연골, 힘줄 및 관절, 뼈 및 치아의 주요 구성 요소이다. 또한, 콜라겐은 근육 기능에 매우 중요하며, 콜라겐 분자는 근육 섬유에 힘과 구조를 제공한다.Collagen has a variety of beneficial properties, and is a major protein in human connective tissue, constituting cartilage, cornea, blood vessels, and skin, etc. Collagen is also a major component of cartilage, tendons and joints, bones and teeth because it is rigid, non-extensible and has excellent tensile strength. Collagen is also very important for muscle function, and collagen molecules provide strength and structure to muscle fibers.
콜라겐 분자는 큰 길이 때문에 소화 시스템에 의해 분해되기가 매우 어렵다. 그러므로, 콜라겐을 의료 분야, 미용분야 또는 건강기능식품 분야에 사용하기 위해서는, 콜라겐을 가수분해(hydrolyzed)하여, 용도 및 적용 부위에 따라 유기체에 의한 동화가 되도록 적정 분자량의 콜라겐을 선택하여 적용해야 한다.Collagen molecules are very difficult to break down by the digestive system because of their large length. Therefore, in order to use collagen in the medical field, beauty field, or health functional food field, collagen must be hydrolyzed, and collagen with an appropriate molecular weight must be selected and applied so that it can be assimilated by the organism according to the use and application site. .
본 발명의 조성물 중 상기 콜라겐 펩타이드는 돈피로부터 추출한 젤라틴(돈피 젤라틴) 유래의 콜라겐 펩타이드로서, 돈피 젤라틴을 특정 효소로 가수분해시켜 제조한 저분자량 콜라겐 펩타이드를 사용한다. 좀 더 구체적으로는, 300 Da 이하의 콜라겐 펩타이드, 바람직하게는 150 ~ 250 Da의 콜라겐 펩타이드, 더욱 바람직하게는 180 ~ 210 Da의 콜라겐 펩타이드를 사용할 수 있다. 이때, 콜라겐 펩타이드의 분자량이 300 Da를 초과하면 콜라겐 펩타이드 성분의 체내 흡수율이 떨어져서 제품의 상품성이 부족할 수 있다.In the composition of the present invention, the collagen peptide is a collagen peptide derived from gelatin (pork skin gelatin) extracted from pork skin, and a low molecular weight collagen peptide prepared by hydrolyzing pork skin gelatin with a specific enzyme is used. More specifically, a collagen peptide of 300 Da or less, preferably a collagen peptide of 150 to 250 Da, and more preferably a collagen peptide of 180 to 210 Da may be used. At this time, if the molecular weight of the collagen peptide exceeds 300 Da, the absorption rate of the collagen peptide component in the body may decrease, resulting in insufficient marketability of the product.
그리고, 본 발명의 조성물 내 콜라겐 펩타이드 함량은 7~15 중량%, 바람직하게는 8.5 ~ 14.0 중량%, 더욱 바람직하게는 9.5 ~ 12.5 중량%를 사용하는 것이 좋으며, 콜라겐 펩타이드 함량이 7 중량% 미만이면 제조하고자 하는 신체 에너지 활성 드링크 분말 제품 내 콜라겐 함량이 낮아서 상품성이 떨어지고, 15 중량%를 초과하여 사용하더라도 콜라겐 체내 흡수량 증대가 없으므로 비경제적이므로 상기 범위 내로 사용하는 것이 적절하다. In addition, the collagen peptide content in the composition of the present invention is preferably 7 to 15% by weight, preferably 8.5 to 14.0% by weight, more preferably 9.5 to 12.5% by weight, and if the collagen peptide content is less than 7% by weight Since the collagen content in the body energy active drink powder product to be manufactured is low, the marketability is poor, and even when used in excess of 15% by weight, it is uneconomical because there is no increase in collagen body absorption, so it is appropriate to use it within the above range.
본 발명의 조성물 중 상기 혈관 확장제는 혈관 확장을 통한 혈액 순화 개선하여, 운동 활동력 증가시키는 역할을 하는 것으로서, L-아르기닌(arginine), 및 시트롤린(citrulliine) 중에서 선택된 1종 이상을 포함할 수 있으며, 바람직하게는 L-아르기닌(arginine) 및 시트롤린(citrulliine)을 포함할 수 있다.The vasodilator in the composition of the present invention serves to improve blood circulation through vasodilation and increase exercise activity, and may include at least one selected from L-arginine and citrulline, , preferably L-arginine and citrulline.
본 발명의 조성물 중 상기 근육회복제는 체지방을 연소시키고, 근 손실을 방지하며, 근 회복 및 근 생성을 촉진하는 역할을 하는 것으로서, L-글루타민(glutamine) 및 비타민 B 복합제 중에서 선택된 1종 이상을, 바람직하게는 L-글루타민(glutamine) 및 비타민 B 복합제를 포함할 수 있다. 더욱 바람직하게는 근육 회복 극대화를 위하여 L-글루타민(glutamine) 100 중량부에 대하여, 비타민 B 복합제 1 ~ 5 중량부를 포함할 수 있다. 이때, 비타민 B 복합제 혼합 사용시 이의 사용량이 5 중량부를 초과하더라도 근 손실, 회복, 촉진 효과 상승이 더 이상 없으므로 상기 범위 내로 사용하는 것이 좋다.The muscle recovery agent in the composition of the present invention serves to burn body fat, prevent muscle loss, and promote muscle recovery and muscle generation, and includes at least one selected from L-glutamine and vitamin B complexes, Preferably, L-glutamine and vitamin B complex may be included. More preferably, in order to maximize muscle recovery, 1 to 5 parts by weight of a vitamin B complex may be included based on 100 parts by weight of L-glutamine. At this time, when using the vitamin B complex mixture, even if the amount of the vitamin B complex exceeds 5 parts by weight, muscle loss, recovery, and promotion effects are no longer increased, so it is good to use it within the above range.
그리고, 상기 비타민 B 복합제는 비타민 B1, B2, B6, B12를 포함하는 복합제이며, 바람직한 일 구현예를 들면, 상기 비타민 B 복합제는 판토텐산칼슘 20 ~ 25 중량%, 비타민B6 염산염 5 ~ 10 중량%, 비타민 B1 염산염 4.0 ~ 7.0 중량%, 비타민 B2 3 ~ 7 중량%, 비타민 B12 2.5 ~ 5.0 중량%, 엽산 0.5 ~ 2.0 중량% 및 100 중량% 중 나머지 잔량의 니코티난 아마이드를 포함하는 복합제를 사용할 수 있으며, 바람직하게는 판토텐산칼슘 21.5 ~ 24.5 중량%, 비타민B6 염산염 6.5 ~ 9.0 중량%, 비타민 B1 염산염 4.0 ~ 6.5 중량%, 비타민 B2 4.0 ~ 6.0 중량%, 비타민B12 3.5 ~ 4.5 중량%, 엽산 0.8 ~ 1.5 중량% 및 100 중량% 중 나머지 잔량의 니코티난 아마이드를 포함하는 복합제를 사용할 수 있다.In addition, the vitamin B complex is a complex preparation containing vitamins B1, B2, B6, and B12, and in a preferred embodiment, the vitamin B complex contains 20 to 25% by weight of calcium pantothenate, 5 to 10% by weight of vitamin B6 hydrochloride, A complex preparation containing 4.0 to 7.0% by weight of vitamin B1 hydrochloride, 3 to 7% by weight of vitamin B2, 2.5 to 5.0% by weight of vitamin B12, 0.5 to 2.0% by weight of folic acid, and the balance of nicotinanamide among 100% by weight may be used. , Preferably 21.5 to 24.5% by weight of calcium pantothenate, 6.5 to 9.0% by weight of vitamin B6 hydrochloride, 4.0 to 6.5% by weight of vitamin B1 hydrochloride, 4.0 to 6.0% by weight of vitamin B2, 3.5 to 4.5% by weight of vitamin B12, 0.8 to 1.5% by weight of folic acid A composite agent containing the balance of nicotinan amide in the remaining amount of 100% by weight and 100% by weight may be used.
본 발명의 조성물 중 상기 노폐물 중성화제는 신체 내 노폐물을 중성화시키고, 혈액 속 pH 수치를 낮추며, 해로운 암모니아를 요소로 바꿔서 소변으로 배출시키는 역할을 하는 것으로서, DL-말릭산(Malic acid), 무수구연산 및 오르니틴염산염 중에서 선택된 1종 이상을 포함할 수 있으며, 바람직하게는 DL-말릭산, 무수구연산 및 오르니틴염산염 3종을 포함할 수 있다. 3종 사용시에는 무수구연산 5 ~ 10 중량%, 오르니틴염산염 2.0 ~ 6.0 중량% 및 100 중량% 중 나머지 잔량의 DL-말릭산을 포함할 수 있으며, 바람직하게는 무수구연산 6.0 ~ 8.5 중량%, 오르니틴염산염 3.0 ~ 5.0 중량% 및 100 중량% 중 나머지 잔량의 DL-말릭산을 포함할 수 있으며, 상기 함량 범위 내로 사용하는 것이 신체 내 노폐물 중성화, 배출 측면에서 유리하다.The waste neutralizer in the composition of the present invention neutralizes wastes in the body, lowers the pH level in the blood, and converts harmful ammonia into urea to be excreted through urine. And ornithine hydrochloride may include at least one selected from, and preferably may include three kinds of DL-malic acid, anhydrous citric acid, and ornithine hydrochloride. When using three types, 5 to 10% by weight of anhydrous citric acid, 2.0 to 6.0% by weight of ornithine hydrochloride, and the remaining DL-malic acid among 100% by weight may be included, preferably 6.0 to 8.5% by weight of anhydrous citric acid, ornithine It may include 3.0 to 5.0% by weight of tin hydrochloride and DL-malic acid of the remaining amount of 100% by weight, and using it within the above content range is advantageous in terms of neutralizing and excreting wastes in the body.
본 발명의 조성물 중 상기 감미료는 천연 감미료 및 인공 감미료를 포함할 수 있으며, 바람직하게는 천연 감미료 및 인공 감미료를 1 : 0.10 ~ 0.25 중량비로, 더욱 바람직하게는 천연 감미료 및 인공 감미료를 1 : 0.12 ~ 0.20 중량비로 혼합 사용하여 인공 감미료 사용량을 최소화시키는 것이 좋다.The sweetener in the composition of the present invention may include a natural sweetener and an artificial sweetener, preferably a natural sweetener and an artificial sweetener in a weight ratio of 1:0.10 to 0.25, more preferably a natural sweetener and artificial sweetener in a weight ratio of 1:0.12 to 0.12. It is recommended to minimize the amount of artificial sweetener used by mixing at a weight ratio of 0.20.
상기 천연 감미료는 자일리톨, 효소 처리 스테비아, 팔라티노스 및 에리스리톨 중에서 선택된 1종 이상을 포함할 수 있고, 바람직하게는 자일리톨, 효소 처리 스테비아, 팔라티노스 및 에리스리톨 중에서 선택된 2종 이상을, 더욱 바람직하게는 자일리톨, 효소 처리 스테비아, 팔라티노스 및 에리스리톨 중에서 선택된 3종 이상을 포함할 수 있다. 상기 효소 처리 스테비아는 스테비아지에스지95를 사용할 수 있다. The natural sweetener may include at least one selected from xylitol, enzyme-treated stevia, palatinose, and erythritol, preferably at least two selected from xylitol, enzyme-treated stevia, palatinose, and erythritol, and more preferably xylitol. , enzyme-treated stevia, palatinose, and erythritol may include three or more selected from. Stevia GS G95 may be used as the enzyme-treated stevia.
또한, 상기 인공 감미료는 아스파탐, 수크랄로스 및 사탕수수 가공 감미료 중에서 선택된 1종 이상을 포함할 수 있고, 바람직하게는 아스파탐, 수크랄로스 및 사탕수수 가공 감미료를 혼합하여 사용하며, 더욱 바람직하게는 아스파탐 100 중량부에 대하여, 수크랄로스 2.0 ~ 5.0 중량부 및 사탕수수 가공 감미료 5.0 ~ 12.0 중량부를 혼합하여 사용할 수 있다.In addition, the artificial sweetener may include at least one selected from aspartame, sucralose, and sugar cane processed sweeteners, preferably using a mixture of aspartame, sucralose, and sugar cane processed sweeteners, more preferably 100 parts by weight of aspartame. , 2.0 to 5.0 parts by weight of sucralose and 5.0 to 12.0 parts by weight of processed sugar cane sweetener may be mixed and used.
그리고, 상기 사탕수수 가공 감미료는 사탕수수 추출물 2.0 ~ 5.0 중량%, 당밀 추출물 1.0 ~ 3.0 중량%, 글리세린 0.50 ~ 1.50 중량%, 합성향료 0.5 ~ 2.0 중량% 및 100 중량% 중 나머지 잔량의 덱스트린을 포함하는 것을 사용할 수 있고, 바람직하게는 사탕수수 추출물 2.3 ~ 4.0 중량%, 당밀 추출물 1.2 ~ 2.6 중량%, 글리세린 0.60 ~ 1.30 중량%, 합성향료 0.75 ~ 1.80 중량% 및 100 중량% 중 나머지 잔량의 덱스트린을 포함하는 것을 사용할 수 있다. 그리고, 상기 합성향료의 일 구현예를 들면, 4,5-다이메틸-3-하이드록시-2,5-다이하이드로퓨란-2-온을 사용할 수 있다. In addition, the sugarcane processed sweetener includes 2.0 to 5.0% by weight of sugarcane extract, 1.0 to 3.0% by weight of molasses extract, 0.50 to 1.50% by weight of glycerin, 0.5 to 2.0% by weight of synthetic flavoring, and 100% by weight of dextrin. can be used, preferably 2.3 to 4.0% by weight of sugar cane extract, 1.2 to 2.6% by weight of molasses extract, 0.60 to 1.30% by weight of glycerin, 0.75 to 1.80% by weight of synthetic flavoring, and the remaining dextrin among 100% by weight Including can be used. In addition, as an example of the synthetic perfume, 4,5-dimethyl-3-hydroxy-2,5-dihydrofuran-2-one may be used.
본 발명의 신체 에너지 활성 드링크 분말 조성물은 앞서 설명한 복합 아미노산, 콜라겐 펩타이드, 혈관 확장제, 근육회복제, 노폐물 중성화제 및 감미료 외에 추가적인 기능성 효과를 부여하기 위해 콜라겐 흡수 보조제, 항산화제, 미네랄 보충제, 칼슘 보충제, 산도조절제 및 향료 중에서 선택된 1종 이상을 더 포함할 수도 있다.The body energy active drink powder composition of the present invention contains collagen absorption aids, antioxidants, mineral supplements, calcium supplements, It may further include at least one selected from an acidity regulator and a flavoring agent.
상기 콜라겐 흡수 보조제는 콜라겐 펩타이드의 체내 흡수율을 증대시키는 역할을 하는 것으로서, 프리바이오틱스 소재를 사용할 수 있고, 바람직한 일례를 들면, 갈락토올리고당을 사용할 수 있다.The collagen absorption aid serves to increase the absorption rate of collagen peptides in the body, and prebiotics materials may be used, and galacto-oligosaccharides may be used as a preferred example.
상기 항산화제는 콜라겐 합성을 촉진하고, 면역력을 증진시키는 역할을 하는 것으로서, 비타민 C(아스코르빈산), 비타민 E(토코페롤) 및 코엔자임Q10 중에서 선택된 1종 이상을 포함할 수 있으며, 바람직하게는 비타민 C 및 비타민 E 중에서 선택된 1종 이상을 포함할 수 있다.The antioxidant serves to promote collagen synthesis and enhance immunity, and may include at least one selected from vitamin C (ascorbic acid), vitamin E (tocopherol), and coenzyme Q10, preferably vitamin C. It may contain at least one selected from C and vitamin E.
상기 미네랄 보충제는 신체에 미네랄을 공급하여 신경계, 소화계통 기능 향상을 위해 사용하는 것으로서, L-락트산 마그네슘(Magnesium Latate)을 포함할 수 있다.The mineral supplement is used to supply minerals to the body to improve functions of the nervous system and digestive system, and may include L-lactate magnesium.
상기 칼슘 보충제는 수용성 칼슘 보충제를 사용할 수 있으며, 일반적으로사용되는 칼슘 보충제를 사용할 수 있으며, 바람직하게는 락트산 칼슘(Calcium lactate) 및 글루콘산 칼슘(Calcium gluconate)를 1 : 0.5 ~ 1.2 중량비로, 더 바림직하게는 락트산 칼슘 및 글루콘산 칼슘을 1 : 0.8 ~ 1.1 중량비로 포함하는 복합 칼슘 보충제를 사용하는 것이, 다른 성분들과의 혼화성, 수용성, 체내 흡수력 측면에서 유리하다.The calcium supplement may use a water-soluble calcium supplement, and a commonly used calcium supplement may be used, preferably calcium lactate and calcium gluconate in a weight ratio of 1: 0.5 to 1.2, more Preferably, using a complex calcium supplement containing calcium lactate and calcium gluconate in a weight ratio of 1:0.8 to 1.1 is advantageous in terms of miscibility with other ingredients, water solubility, and absorption in the body.
상기 산도조절제는 제품의 산도를 조절하여 수용성, 체내 흡수률 측면에서 드링크 분말이 물에 용해되거나, 용해 된 후, 적정 산도를 가지도록 조절하는 역할을 하는 것으로서, 상기 산도조절제는 구연산나트륨을 사용하는 것이 좋다.The acidity regulator serves to adjust the acidity of the product so that the drink powder dissolves in water or has a titratable acidity after dissolving in terms of water solubility and absorption in the body, and the acidity regulator is to use sodium citrate. good night.
상기 향료는 감미료와 함께 사용되어 신체 에너지 활성 드링크 분말 제품에 맛과 향을 부여하여 상품성을 증대시키는 역할을 하는 것으로서, 제조하고자 하는 제품의 맛, 향을 고려하여 식품, 의약 업계에서 사용 허가된, 일반적인 소재의 향료를 선택하여 사용할 수 있다. 바람직한 일 구현예를 들면, 제품에 레몬 맛과 향을 부여하고자 하는 경우, 레몬과즙분말과 레몬라임향 제제를 혼합하여 사용할 수 있다.The flavoring is used together with a sweetener to impart taste and aroma to the body energy active drink powder product to increase marketability, and is licensed for use in the food and pharmaceutical industries in consideration of the taste and aroma of the product to be manufactured, You can choose and use the fragrance of general materials. In a preferred embodiment, in the case of imparting a lemon taste and aroma to a product, a mixture of lemon juice powder and a lemon-lime flavoring agent may be used.
앞서 설명한 복합 아미노산, 콜라겐 펩타이드, 혈관 확장제, 근육회복제, 노폐물 중성화제, 감미료, 콜라겐 흡수 보조제, 항산화제, 미네랄 보충제, 칼슘 보충제, 산도조절제, 향료를 포함하는 신체 에너지 활성 드링크 분말 조성물은 기능성 성분들의 체내 흡수율, 조성물간 혼화성, 드링크 분말의 수용성, 맛과 향의 상품성 등을 고려할 때, 바람직한 일 구현예를 들면, 하기 표 1과 같은 조성비를 가지도록 성분들 혼합하여 제조하는 것이 좋다.The body energy active drink powder composition, which includes the aforementioned complex amino acids, collagen peptides, vasodilators, muscle recovery agents, waste neutralizers, sweeteners, collagen absorption aids, antioxidants, mineral supplements, calcium supplements, acidity regulators, and flavors, contains functional ingredients. Considering absorption rate in the body, miscibility between compositions, water solubility of drink powder, productability of taste and aroma, etc., it is preferable to prepare by mixing the ingredients to have the composition ratio shown in Table 1 below, for example.
이하, 본 발명을 하기 실시예에 의거하여 보다 상세하게 설명하고자 한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본발명은 하기 실시예에 의해 한정되는 것이 아니고, 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 치환 및 균등한 타 실시예로 변경할 수 있음은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 명백할 것이다.Hereinafter, the present invention will be described in more detail based on the following examples. However, the following examples are only for exemplifying the present invention, the present invention is not limited by the following examples, and may be changed to other equivalent examples without departing from the technical spirit of the present invention. will be clear to those skilled in the art to which the present invention pertains.
[실시예][Example]
실시예 1 : 신체 에너지 활성 드링크 분말 제조Example 1: Preparation of body energy active drink powder
(1) 복합 아미노산 제조(1) Manufacture of complex amino acids
L-로이신 49.970 중량%, L-이소로이신 24.985 중량%, L-발린 24.985 중량% 및 L-레시틴 0.060 중량%를 포함하는 복합 아미노산을 준비하였다.A complex amino acid containing 49.970% by weight of L-leucine, 24.985% by weight of L-isoleucine, 24.985% by weight of L-valine, and 0.060% by weight of L-lecithin was prepared.
(2) 저분자량 콜라겐 펩타이드 준비(2) Preparation of low molecular weight collagen peptides
돈피로부터 추출한 젤라틴을 효소와 물을 사용하여 가수분해하여 제조한 분자량 197 Da의 저분자량 콜라겐 펩타이드를 준비하였다(제조사:코리아콜라겐 주식회사, 상품명 :콜라겐펩타이드-PP)A low molecular weight collagen peptide with a molecular weight of 197 Da prepared by hydrolyzing gelatin extracted from pork skin using enzymes and water was prepared (manufacturer: Korea Collagen Co., Ltd., product name: Collagen Peptide-PP)
(3) 근육회복제(비타민 B 복합제)의 제조(3) Preparation of muscle recovery agent (vitamin B complex)
판토텐산칼슘 22.94 중량%, 비타민 B6 염산염 7.61 중량%, 비타민 B1 염산염 5.52 중량%, 비타민 B2 5.08 중량%, 비타민 B12 제제 3.68 중량%, 엽산 1.07 중량% 및 100 중량% 중 나머지 잔량의 니코틴산 아마이드를 혼합 및 가공하여 근육회복제로서, 비타민 B 복합제를 제조하였다. 이때, 상기 비타민 B12 제제는 구연산나트륨 3 중량%, 구연산 1 중량%, 비타민 B12 0.1 중량% 및 덱스트린 95.9 중량%를 포함한다.22.94% by weight of calcium pantothenate, 7.61% by weight of vitamin B6 hydrochloride, 5.52% by weight of vitamin B1 hydrochloride, 5.08% by weight of vitamin B2, 3.68% by weight of vitamin B12 preparation, 1.07% by weight of folic acid, and the remaining balance of nicotinic acid amide of 100% by weight Mixing and As a muscle recovery agent by processing, a vitamin B complex was prepared. In this case, the vitamin B12 formulation includes 3% by weight of sodium citrate, 1% by weight of citric acid, 0.1% by weight of vitamin B12, and 95.9% by weight of dextrin.
(4) 사탕수수 가공 감미료 제조(4) Manufacture of sugar cane processed sweetener
사탕수수 추출물 2.55 중량%, 당밀 추출물 1.76 중량%, 글리세린 0.91 중량%, 4,5-디메틸-3-하이드록시-2,5-다이하이드로퓨란-2-온 1.02 중량% 및 덱스트린 93.76 중량%를 혼합 및 가공하여 사탕수수 가공 감미료를 제조하였다.2.55% by weight of sugar cane extract, 1.76% by weight of molasses extract, 0.91% by weight of glycerin, 1.02% by weight of 4,5-dimethyl-3-hydroxy-2,5-dihydrofuran-2-one and 93.76% by weight of dextrin were mixed. And processed to prepare a sugarcane processed sweetener.
(5) 신체 에너지 활성 드링크 분말(5) body energy active drink powder
앞서 준비한 분자량 197 Da의 콜라겐 펩타이드 10 중량%, L-아르기닌(혈관확장제), 근육회복제 6.1 중량%, 노폐물 중성화제 23.7 중량%, 천연 감미료 및 인공 감미료를 1:0.17 중량비로 혼합한 감미료 18.82 중량%, 갈록토올리고당(콜라겐 흡수 보조제) 1 중량%, 비타민 C(항산화제) 1 중량%, L-락트산 마그네슘(미네랄 보충제) 0.2 중량%, 락트산 칼슘 및 글루콘산 칼슘을 1:1 중량비로 혼합하여 제조한 칼슘보충제 0.2 중량%, 구연산 나트륨(산도 조절제) 0.2 중량% 및 100 중량% 중 나머지 잔량의 앞서 제조한 복합 아미노산을 혼합하여 신체 에너지 활성 드링크 분말을 제조하였다(표 2 참조).10% by weight of previously prepared collagen peptide with a molecular weight of 197 Da, L-arginine (vasodilator), 6.1% by weight of muscle recovery agent, 23.7% by weight of waste neutralizer, 18.82% by weight of sweetener mixed with natural sweetener and artificial sweetener at a weight ratio of 1:0.17 Prepared by mixing galacto-oligosaccharide (collagen absorption aid) 1% by weight, vitamin C (antioxidant) 1% by weight, L-magnesium lactate (mineral supplement) 0.2% by weight, calcium lactate and calcium gluconate in a 1:1 weight ratio A body energy active drink powder was prepared by mixing 0.2% by weight of a calcium supplement, 0.2% by weight of sodium citrate (acidity regulator) and the remaining balance of 100% by weight of the previously prepared complex amino acids (see Table 2).
이때, 상기 근육회복제는 L-글루타민(glutamine) 100 중량부에 대하여 앞서 제조한 비타민 B 복합제 1.67 중량부를 혼합하여 제조한 것을 사용하였다.At this time, the muscle recovery agent was prepared by mixing 1.67 parts by weight of the previously prepared vitamin B complex with respect to 100 parts by weight of L-glutamine.
상기 노폐물 중성화제는 무수구연산 7.17 중량%, 오르니틴염산염 4.22 중량% 및 100 중량% 중 나머지 잔량의 DL-말릭산을 혼합하여 제조한 것을 사용하였다.The waste neutralizing agent was prepared by mixing 7.17% by weight of anhydrous citric acid, 4.22% by weight of ornithine hydrochloride, and 100% by weight of the balance of DL-malic acid.
상기 천연 감미료는 자일리톨 36.04 중량%, 효소 처리 스테비아(스테비아지에스지 95) 1.24 중량%, 팔라티노스(palatinose) 32.58 중량% 및 100 중량% 중 나머지 잔량의 에리스리톨을 혼합하여 제조한 것을 사용하였다.The natural sweetener was prepared by mixing 36.04% by weight of xylitol, 1.24% by weight of enzyme-treated stevia (Stevia GS G 95), 32.58% by weight of palatinose, and the balance of erythritol among 100% by weight.
상기 인공 감미료는 아스파탐 100 중량부에 대하여, 수크랄로스 2.35 중량부 및 앞서 제조한 상기 사탕수수 가공 감미료 8.1 중량부를 혼합하여 제조한 것을 사용하였다.The artificial sweetener was prepared by mixing 2.35 parts by weight of sucralose and 8.1 parts by weight of the previously prepared sugarcane processed sweetener based on 100 parts by weight of aspartame.
제조한 신체 에너지 활성 드링크 분말 10g을 파우치(1회용 포장체)에 포장하였다(도 1 참조). 10 g of the prepared body energy active drink powder was packaged in a pouch (disposable package) (see FIG. 1).
상기 파우치 1포는 신체 에너지 활성 드링크 분말 10g을 포함하고, 신체 에너지 활성 드링크 분말 10g 당 아미노산의 총 함량(L-로이신, L-이소로이신, L-발린, 글루타민, 아르기닌)이 4,000 mg 이상이고, 콜라겐 펩타이드 함량이 1,000 mg 이상이었다.One pouch contains 10 g of body energy active drink powder, and the total content of amino acids (L-leucine, L-isoleucine, L-valine, glutamine, arginine) per 10 g of body energy active drink powder is 4,000 mg or more, The collagen peptide content was 1,000 mg or more.
실시예 2 Example 2
상기 실시예 1과 동일한 신체 에너지 활성 드링크 분말을 제조하되, 하기 교 1과 같이 저분자 콜라겐 펩타이드 함량을 증가시키고 이와 함께 콜라겐 흡수 보조제 함량도 증가시켜서 신체 에너지 활성 드링크 분말을 제조하였다.The same body energy active drink powder as in Example 1 was prepared, but the body energy active drink powder was prepared by increasing the low-molecular-weight collagen peptide content and increasing the collagen absorption adjuvant content as in Example 1 below.
비교예 1Comparative Example 1
상기 실시예 1과 동일한 신체 에너지 활성 드링크 분말을 제조하되, 콜라겐 펩타이드로서, 분자량 197 Da의 저분자량 콜라겐 펩타이드 대신 분자량 354 Da의 콜라겐 펩타이드를 사용하여 하기 표 2의 조성을 가지는 신체 에너지 활성 드링크 분말을 제조하였다.The same body energy active drink powder as in Example 1 was prepared, but as collagen peptides, collagen peptides having a molecular weight of 354 Da instead of low molecular weight collagen peptides having a molecular weight of 197 Da were used to prepare a body energy active drink powder having the composition shown in Table 2 below did
비교예 2Comparative Example 2
상기 실시예 1과 동일한 신체 에너지 활성 드링크 분말을 제조하되, 콜라겐 흡수 보조제를 사용하지 않고, 신체 에너지 활성 드링크 분말을 제조하였으며, 콜라겐 펩타이드를 11 중량%로 사용하였다.The same body energy active drink powder as in Example 1 was prepared, but without the use of a collagen absorption adjuvant, the body energy active drink powder was prepared, and collagen peptides were used at 11% by weight.
비교예 3Comparative Example 3
상기 실시예 1과 동일한 신체 에너지 활성 드링크 분말을 제조하되, 하기 표 1과 같이 콜라겐 펩타이드를 16 중량%로 사용하고, 콜라겐 흡수보조재 사용량을 증가시켜서 신체 에너지 활성 드링크 분말을 제조하였다.The same body energy active drink powder as in Example 1 was prepared, but collagen peptides were used at 16% by weight as shown in Table 1 below, and the body energy active drink powder was prepared by increasing the amount of collagen absorption aid.
실험예 1 : 혈중으로의 이행성 시험(체내 흡수성 시험)Experimental Example 1: Transition into blood test (body absorption test)
시험은 이와이 등의 보고(문헌[Agric. Food Chem., 2005, Vol.53, No.16, p6531-[0075] 6536])에 기초하여 행하였다The test was conducted based on the report of Iwai et al. (Agric. Food Chem., 2005, Vol.53, No.16, p6531-[0075] 6536])
피험자(실험 참가자) 10명에 대하여 6 일간 이상의 워시 아웃(wash out) 기간을 두고, 피험자 1인에 대하여 상기 실시예 및 비교예의 신체 에너지 활성 드링크 분말을 피검 시료로 하여, 각각 1회 섭취시키는 크로스오버 시험으로 수행하였다. 피검시료 종류 당 피험자 2명에게 동일한 피검시료를 섭취시켜서 시험을 수행하였고, 그 평균값을 측정하였고 그 결과를 하기 표 4에 나타내었다.A cross in which 10 subjects (experiment participants) have a wash out period of 6 days or more, and each subject ingests the body energy active drink powder of the above examples and comparative examples once as a test sample. It was performed as an over test. The test was performed by ingesting the same test sample to two subjects per type of test sample, and the average value was measured, and the results are shown in Table 4 below.
피험자는 12 시간의 절식 후, 섭취 전 채혈을 행하고, 각 피검 시료(실시예 또는 비교예)를 섭취하였다. 신체 에너지 활성 드링크 분말(피검 시료)를 물 500ml에 녹인 후, 섭취하였다. After fasting for 12 hours, the test subject performed blood sampling before ingestion, and ingested each test sample (Example or Comparative Example). After dissolving the body energy active drink powder (test sample) in 500 ml of water, it was consumed.
그리고, 섭취 30분 및 1 시간 경과 시점에 각각 5 mL 채혈하였으며, 약 15 분간 얼음 중에서 방치시킨 후, 원심 분리(3,000 rpm, 15 분, 4℃)를 행하여 혈장을 얻었다.Then, 5 mL of blood was collected at 30 minutes and 1 hour after ingestion, respectively, and after leaving it on ice for about 15 minutes, it was centrifuged (3,000 rpm, 15 minutes, 4°C) to obtain plasma.
혈장 300 μL에 에탄올 900 μL를 첨가하여 볼텍스(vortex)로 15 초간 교반하고, 원심 분리(12,000 rpm, 10 분, 4℃)하여 상청을 얻었다. 각 피험자, 각 채혈 시간의 혈장을 분석할 때까지 -80℃에서 동결 보존하였다.900 μL of ethanol was added to 300 μL of plasma, stirred for 15 seconds by vortex, and centrifuged (12,000 rpm, 10 minutes, 4° C.) to obtain a supernatant. Plasma from each subject at each blood collection time was cryopreserved at -80°C until analysis.
혈장 중의 펩타이드형 하이드록시프롤린량은, 총 하이드록시프롤린량과 유리형 히드록시프롤린량을 각각 측정하고, (총 하이드록시프롤린량 - 유리형 히드록시프롤린량)으로 계산하였다. 이때, 상기 총 히드록시프롤린은 혈장 샘플을 6 N 염산을 이용해 가수분해 후, 페닐이 소티오시아네이트(PITC) 유도하고, 하기 조건에서 HPLC를 행하여 측정하였다. 또한, 혈장 중의 유리형 히드록시 프롤린량은 단백 제거한 혈장 샘플에 대하여 동일한 조건에서 HPLC를 행하여 측정하였고, HLPC 분석 조건은 하기 표 3과 같다. The amount of peptide-type hydroxyproline in plasma was calculated by measuring the total amount of hydroxyproline and the amount of free hydroxyproline, respectively, and calculating the total amount of hydroxyproline - the amount of free hydroxyproline. At this time, the total hydroxyproline was measured by hydrolyzing the plasma sample with 6 N hydrochloric acid, inducing phenyl isothiocyanate (PITC), and performing HPLC under the following conditions. In addition, the amount of free hydroxyproline in plasma was measured by performing HPLC under the same conditions with respect to the protein-removed plasma sample, and the HLPC analysis conditions are shown in Table 3 below.
그리고, 신체 에너지 활성 드링크 분말 섭취 후 30분 및 1시간 경과 시점의 펩타이드형 하이드록시프롤린양의 평균값을 하기 표 4에 나타내었다.In addition, the average values of the amount of peptide-type hydroxyproline at 30 minutes and 1 hour after ingestion of the body energy active drink powder are shown in Table 4 below.
(nmol/ml)When 30 minutes have elapsed
(nmol/ml)
(nmol/ml)1 hour elapsed point
(nmol/ml)
상기 표 4의 콜라겐의 혈중 이행성 시험 결과를 살펴보면, 신체 에너지 활성 드링크 분말 제조시, 분자량이 300 Da을 초과한 354 Da의 콜라겐 펩타이드를 사용하여 제조한 비교예 1의 경우, 분자량이 300 Da 미만인 저분자량 콜라겐 펩타이를 사용하여 제조한 실시예 1 ~ 2 및 비교예 2 ~ 3의 신체 에너지 활성 드링크 분말와 비교할 때, 콜라겐 체내 흡수율이 크게 떨어지는 것을 확인할 수 있었다.Looking at the blood transferability test results of collagen in Table 4, in the case of Comparative Example 1 prepared using a collagen peptide having a molecular weight of more than 300 Da and 354 Da when preparing a body energy active drink powder, the molecular weight was less than 300 Da Compared to the body energy active drink powders of Examples 1 to 2 and Comparative Examples 2 to 3 prepared using low molecular weight collagen peptides, it was confirmed that the absorption rate of collagen in the body was greatly reduced.
또한, 콜라겐 흡수 보조제를 사용하지 않은 비교예 2의 경우, 실시예 1과비교할 때, 콜라겐 펩타이드 함량이 다소 높음에도 불구하고, 오히려 체내 흡수량뿐만 아니라, 체내 흡수 속도로 급격하게 감소하는 결과를 보였다.In addition, in the case of Comparative Example 2, which did not use a collagen absorption aid, when compared to Example 1, although the collagen peptide content was somewhat higher, rather, not only the amount absorbed into the body, but also the rate of absorption into the body rapidly decreased.
그리고, 콜라겐 펩타이드 함량이 15 중량%를 초과한 16.0 중량%를 사용하고, 콜라겐 흡수 보조제 함량을 증가시킨 비교예 3의 경우, 실시예 2와 비교할 때, 콜라겐 펩타이드 및 콜라겐 흡수 보조제 함량 증가에도 불구하고, 체내 콜라겐 흡수량이뿐만 아니라, 체내 흡수 속도 증가도 미비하였다.And, in the case of Comparative Example 3 in which the collagen peptide content was more than 15% by weight and 16.0% by weight was used and the content of the collagen absorption aid was increased, compared to Example 2, despite the increase in the content of collagen peptide and collagen absorption aid , not only the amount of collagen absorbed in the body, but also the increase in the rate of absorption in the body was insufficient.
실시예 3 ~ 4 및 비교예 4 ~ 5Examples 3 to 4 and Comparative Examples 4 to 5
상기 실시예 1과 동일한 방법으로 신체 에너지 활성 드링크 분말을 제조하되, 하기 표 5와 같이 노폐물 중성화제, 감미료 및 향료 함량을 달리하여 실시예 3 ~ 4 및 비교예 4 ~ 5를 각각 실시하였다.Body energy active drink powder was prepared in the same manner as in Example 1, but Examples 3 to 4 and Comparative Examples 4 to 5 were carried out by varying the content of the waste neutralizer, sweetener and flavoring agent as shown in Table 5 below.
실험예 2 : 관능평가Experimental Example 2: Sensory evaluation
50명의 패널에게 실시예 1, 3 ~ 4 및 비교예 3 ~ 4에서 제조한 신체 에너지 활성 드링크 분말 10g을 물 500 ml에 녹인 후, 이를 섭취한 다음 맛, 향 및 전체적 기호도를 평가하도록 하였고 그 결과를 하기 표 6에 나타내었다. 평가는 5점 타점법(5점 : 아주 우수함, 4점 : 우수함, 3 점 : 보통, 2점 : 나쁨, 1점 : 아주나쁨)으로 평가하였으며,점수가 높을수록 기호도가 높은 것을 의미하였다.50 panelists were asked to dissolve 10 g of the body energy active drink powder prepared in Examples 1, 3 to 4 and Comparative Examples 3 to 4 in 500 ml of water, ingest it, and then evaluate the taste, aroma and overall preference. As a result, are shown in Table 6 below. The evaluation was evaluated by a 5-point scoring system (5 points: very good, 4 points: excellent, 3 points: normal, 2 points: bad, 1 point: very bad), and higher scores meant higher preference.
상기 표 6을 살펴보면, 실시예 1 및 실시예 3 ~ 4는 맛, 향과 종합적인 기호도 모두 전반적으로 4점 이상의 우수한 관능 평가를 받았다.Looking at Table 6, Example 1 and Examples 3 and 4 received an excellent sensory evaluation of 4 points or more overall in terms of taste, aroma, and overall preference.
이에 반해, 노폐물 중성화제를 25 중량% 초과 및 감미료 함량을 15 중량%이상미만으로 사용한 비교예 4의 경우, 느끼한 맛이 다소 난다는 평가를 다소 받았으며, 종합적인 기호도가 크게 떨어지는 평가를 받았다.On the other hand, in Comparative Example 4, in which the waste neutralizing agent was used in an amount of more than 25% by weight and the content of the sweetener was less than 15% by weight or more, it was evaluated that the taste was slightly greasy, and the overall preference was greatly lowered.
또한, 감미료 함량을 크게 증가하여 제조한 비교예 5의 경우, 오히려 단맛이 너무 강하다는 평가를 받아서, 맛과 종합적인 기호도 평가가 좋지 않았다.In addition, in the case of Comparative Example 5 prepared by greatly increasing the content of the sweetener, rather, it was evaluated that the sweetness was too strong, and the taste and overall preference were not good.
실시예 5 및 비교예 6Example 5 and Comparative Example 6
상기 실시예 1과 동일한 방법으로 신체 에너지 활성 드링크 분말을 제조하되, 하기 표 7과 같이 혈관 확장제 및 근육회복제 함량을 달리하여 실시예 5 및 비교예 6을 각각 실시하였다.Body energy active drink powder was prepared in the same manner as in Example 1, but Example 5 and Comparative Example 6 were carried out by varying the contents of the vasodilator and muscle recovery agent as shown in Table 7 below.
실험예 3 : 무기력감 및 피로감 개선 효과Experimental Example 3: Helplessness and Fatigue Improvement Effect
신체 에너지 활성 드링크 분말의 신체 에너지 활성 효과 발현은 매우 빠르게 발현되지만, 이러한 효과가 주관적일 수 있기 때문에, 다음과 같은 방법을 통해 신체 에너지 활성 평가를 수행하였다. Although the expression of the body energy activity effect of the body energy activity drink powder is expressed very quickly, since this effect may be subjective, the body energy activity evaluation was performed through the following method.
실시예 1, 실시예 5 및 비교예 6에서 제조한 신체 에너지 활성 드링크 분말을 종류별로 명의 30명의 패널에게 매일 1회 1포씩 복용하게 하였으며, 2 주일간 복용 후 무기력감 및 피로감 개선 정도를 5점 타점법(5점 : 아주 우수함, 4점 : 우수함, 3 점 : 보통, 2점 : 나쁨, 1점 : 아주나쁨)으로 평가하였고, 그 결과를 하기 표 8에 나타내었다. The body energy active drink powder prepared in Example 1, Example 5, and Comparative Example 6 was given to 30 panelists by type and taken once daily, and the degree of improvement in lethargy and fatigue after taking for 2 weeks was scored using a 5-point scoring method. (5 points: very good, 4 points: excellent, 3 points: normal, 2 points: bad, 1 point: very bad), and the results are shown in Table 8 below.
이때, 패널은 신진대사가 왕성한 19세 ~ 25세를 대상으로 하였고, 10명은 실시예 1을, 10명은 실시예 5를, 10명은 비교예 6을 섭취하도록 하였다.At this time, the panel was targeted at 19 to 25 years of age with active metabolism, and 10 people took Example 1, 10 people took Example 5, and 10 people took Comparative Example 6.
상기 표 8의 평가 결과를 살펴보면, 혈관확장제 함량 2.5 중량% 미만 및 근육회복제 함량 4.0 중량% 미만으로 사용한 비교예 6의 경우, 실시예 1과 실시예 5와 비교할 때 상대적으로 낮은 무기력감, 피로감 개선 평가를 받았다.Looking at the evaluation results in Table 8, in the case of Comparative Example 6 using a vasodilator content of less than 2.5% by weight and a muscle recovery agent content of less than 4.0% by weight, compared to Examples 1 and 5, relatively low lethargy and fatigue improvement evaluation received
이에 반해, 실시예 1 및 실시예 5는 높은 무기력감 및 피로감 개선 효과가 있다면 평가를 받았다. On the other hand, Examples 1 and 5 were evaluated if they had high lethargy and fatigue improvement effects.
이상에서 본 발명의 일 실시예에 대하여 설명하였으나, 본 발명의 사상은 본 명세서에 제시되는 실시예에 제한되지 아니하며, 본 발명의 사상을 이해하는 당업자는 동일한 사상의 범위 내에서, 구성요소의 부가, 변경, 삭제, 추가 등에 의해서 다른 실시예를 용이하게 제안할 수 있을 것이나, 이 또한 본 발명의 사상범위 내에 든다고 할 것이다.Although one embodiment of the present invention has been described above, the spirit of the present invention is not limited to the embodiments presented herein, and those skilled in the art who understand the spirit of the present invention may add elements within the scope of the same spirit. However, it will be possible to easily suggest other embodiments by means of changes, deletions, additions, etc., but this will also be said to fall within the scope of the present invention.
Claims (10)
상기 복합 아미노산은 L-로이신, L-이소로이신, L-발린 및 L-레시틴을 포함하며,
상기 콜라겐 펩타이드는 150 ~ 210 Da의 저분자량 콜라겐 펩타이드를 포함하고,
상기 콜라겐 흡수 보조제는 갈락토올리고당을 포함하는 것을 특징으로 하는 신체 에너지 활성 드링크 분말 조성물.
Collagen peptide 7-15 wt%, vasodilator 2.5-5.5 wt%, muscle recovery agent 4.0-8.5 wt%, waste neutralizer 20-25 wt%, sweetener 15-21 wt%, collagen absorption aid 0.1-2.0 wt% and the rest Contains residual amounts of complex amino acids,
The complex amino acids include L-leucine, L-isoleucine, L-valine and L-lecithin,
The collagen peptide includes a low molecular weight collagen peptide of 150 ~ 210 Da,
The body energy active drink powder composition, characterized in that the collagen absorption aid comprises galacto-oligosaccharide.
The body energy active drink powder composition according to claim 1, wherein the vasodilator comprises at least one selected from L-arginine and citrulliine.
상기 비타민 B 복합제는 판토텐산칼슘 20 ~ 25 중량%, 비타민 B6 염산염 5 ~ 10 중량%, 비타민 B1 염산염 4.0 ~ 7.0 중량%, 비타민 B2 3 ~ 7 중량%, 비타민 B12 2.5 ~ 5.0 중량%, 엽산 0.5 ~ 2.0 중량% 및 100 중량% 중 나머지 잔량의 니코틴산 아마이드를 포함하는 것을 특징으로 하는 신체 에너지 활성 드링크 분말 조성물.
The method of claim 1, wherein the muscle recovery agent includes L- glutamine and vitamin B complex,
The vitamin B complex contains 20 to 25% by weight of calcium pantothenate, 5 to 10% by weight of vitamin B6 hydrochloride, 4.0 to 7.0% by weight of vitamin B1 hydrochloride, 3 to 7% by weight of vitamin B2, 2.5 to 5.0% by weight of vitamin B12, and 0.5 to 10% by weight of folic acid A body energy active drink powder composition comprising 2.0% by weight and the remaining balance of nicotinic acid amide among 100% by weight.
상기 감미료는 천연 감미료 및 인공 감미료를 포함하는 것을 특징으로 하는 신체 에너지 활성 드링크 분말 조성물.
The method of claim 1, wherein the waste neutralizing agent includes DL- Malic acid, anhydrous citric acid and ornithine hydrochloride,
The body energy active drink powder composition, characterized in that the sweetener comprises a natural sweetener and an artificial sweetener.
상기 인공 감미료는 아스파탐, 수크랄로스 및 사탕수수 가공 감미료 중에서 선택된 1종 이상을 포함하는 것을 특징으로 하는 신체 에너지 활성 드링크 분말 조성물.
The method of claim 6, wherein the natural sweetener includes at least one selected from xylitol, enzyme-treated stevia, palatinose, and erythritol,
The artificial sweetener is a body energy active drink powder composition, characterized in that it comprises at least one selected from aspartame, sucralose and sugar cane processing sweetener.
The method of claim 7, wherein the sugar cane processed sweetener is 2.0 to 5.0% by weight of sugarcane extract, 1.0 to 3.0% by weight of molasses extract, 0.50 to 1.50% by weight of glycerin, 0.5 to 2.0% by weight of synthetic flavoring, and the remainder of 100% by weight. Body energy active drink powder composition, characterized in that it comprises a dextrin of.
The body energy active drink powder composition according to claim 1, further comprising at least one selected from antioxidants, mineral supplements, calcium supplements, acidity regulators and flavoring agents.
상기 혼합물 10g 당 아미노산 함량 3,000 ~ 7,000 mg 및 콜라겐 펩타이드 함량 800 mg 이상으로 포함하는 것을 특징으로 하는 신체 에너지 활성 드링크 분말.It comprises a mixture of the composition of any one of claims 1 and 4 to 9,
A body energy active drink powder comprising 3,000 to 7,000 mg of amino acid content and 800 mg or more of collagen peptide content per 10 g of the mixture.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020220086929 | 2022-07-14 | ||
| KR20220086929 | 2022-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102517807B1 true KR102517807B1 (en) | 2023-04-05 |
Family
ID=85884844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020220112615A KR102517807B1 (en) | 2022-07-14 | 2022-09-06 | Drinking powder composition for boosting body-energy and Drinking powder for boosting body-energy containing the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102517807B1 (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100094485A (en) * | 2007-10-31 | 2010-08-26 | 메이지뉴교오가부시기가이샤 | Anti-fatigue agent comprising amino acid composition |
| KR20120084742A (en) * | 2009-09-30 | 2012-07-30 | 후지필름 가부시키가이샤 | Process for production of composition containing collagen peptide |
| KR20140129439A (en) * | 2013-04-29 | 2014-11-07 | 코오롱제약주식회사 | Food composition for relieving muscle fatigue after exercise |
| KR20150081034A (en) | 2014-01-03 | 2015-07-13 | 충청남도 | The method for manufacuting sports drink using fermentation of ginseng radix, schizandrae fructus and liriopis tuber, and the sports drink made by the method |
| KR20170044701A (en) | 2014-09-22 | 2017-04-25 | 니혼 쇼꾸힌 카코 가부시키가이샤 | Slowly-digestible long-acting energy-supplying agent |
| KR20170137703A (en) | 2015-01-16 | 2017-12-13 | 웰드링스 엘티디 | Beverage with collagen and additional additives |
| KR20210153178A (en) * | 2020-06-09 | 2021-12-17 | (주)세울코퍼레이션 | Composition for promoting absorption of collagen and synthesis of collagen |
-
2022
- 2022-09-06 KR KR1020220112615A patent/KR102517807B1/en active IP Right Grant
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100094485A (en) * | 2007-10-31 | 2010-08-26 | 메이지뉴교오가부시기가이샤 | Anti-fatigue agent comprising amino acid composition |
| KR20120084742A (en) * | 2009-09-30 | 2012-07-30 | 후지필름 가부시키가이샤 | Process for production of composition containing collagen peptide |
| KR20140129439A (en) * | 2013-04-29 | 2014-11-07 | 코오롱제약주식회사 | Food composition for relieving muscle fatigue after exercise |
| KR20150081034A (en) | 2014-01-03 | 2015-07-13 | 충청남도 | The method for manufacuting sports drink using fermentation of ginseng radix, schizandrae fructus and liriopis tuber, and the sports drink made by the method |
| KR20170044701A (en) | 2014-09-22 | 2017-04-25 | 니혼 쇼꾸힌 카코 가부시키가이샤 | Slowly-digestible long-acting energy-supplying agent |
| KR20170137703A (en) | 2015-01-16 | 2017-12-13 | 웰드링스 엘티디 | Beverage with collagen and additional additives |
| KR20210153178A (en) * | 2020-06-09 | 2021-12-17 | (주)세울코퍼레이션 | Composition for promoting absorption of collagen and synthesis of collagen |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Higgins et al. | Energy beverages: content and safety | |
| US7160565B2 (en) | Hydration beverage and method of delivering nutrients | |
| JP3907964B2 (en) | Mental fatigue reducing composition, concentration maintenance enhancing composition and mental vitality maintenance enhancing composition | |
| US20050276839A1 (en) | Appetite satiation and hydration beverage | |
| ES2780573T3 (en) | Food composition containing amino acids and cocoa | |
| US20030143311A1 (en) | Recovery drink formula and method | |
| US11285124B2 (en) | Compositions and methods for increasing muscle mass and strength, treating skin, reducing wear and degradation from aging and exposure and improving recovery from stress such as exercise and trauma | |
| CN104509919A (en) | Functional nutrient beverage | |
| CN103918965A (en) | Physical fatigue alleviating beverage | |
| US9872871B2 (en) | Compositions for use in restoring muscle glycogen and/or muscle mass | |
| WO2013028333A1 (en) | Edible strips | |
| TW200913988A (en) | Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient | |
| US20030091615A1 (en) | Use of betaine to enhance exercise performance | |
| CN105495582A (en) | Anti-fatigue and restorative health-care food amino acid composition | |
| US20060172016A1 (en) | Muscle cramp reliever | |
| US20030104107A1 (en) | Energy drink formula and method | |
| JPH04278061A (en) | Nutritious food | |
| JP2006193435A (en) | Fatigue-improving agent | |
| JP4610499B2 (en) | Food composition | |
| KR102517807B1 (en) | Drinking powder composition for boosting body-energy and Drinking powder for boosting body-energy containing the same | |
| JP2003535120A (en) | Low carbohydrate compositions, kits thereof, and methods of using the same | |
| JP2005213185A (en) | Energy-supplementary and anti-fatigue food and beverage | |
| AU2011300376B2 (en) | Ingredients derived from Sphaeranthus indicus | |
| KR20160048812A (en) | A dietary supplement comprising amino acids in a palatable liquid formulation that promotes restful sleep, recovery from stress and exercise and strengthens the immune system | |
| JP6910583B2 (en) | Heart rate increase suppressing method and heart rate increase suppressing composition during exercise |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |